FDA Approves Eli Lilly's Foundayo Oral Weight-Loss Pill
The FDA has approved Eli Lilly's Foundayo, a once-daily oral GLP-1 weight-loss drug, marking the second such pill after Novo Nordisk's Wegovy. It offers flexible dosing and aims to improve accessibility for obesity treatment.


